5 results
The primary objective is to obtain post-market clinical data according to the requirements of the MEDDEV 2.21/2 in order to fulfil 18 post-market surveillance (PMS) obligations according to Section 3.1 of Annex II, 19 Section 3 of Annex IV, Section…
This protocol is designed to determine the safety, tolerability, and efficacy of SGI-110 in combination with irinotecan in previously treated patients with metastatic colorectal cancer who progressed on irinotecan.
To quantify the role of different abnormal loading conditions on atrial and ventricular electropathology in paediatric patients with CHD.
to demonstrate persistent atrial fibrillation is associated with endocardial and epicardial dissociation of the heart.
To elucidate the correlation between proteostasis marker levels in serum and atrial tissue, and initiation and progression of AF in patients.